BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018-1026. [PMID: 18768945 DOI: 10.1056/nejmoa0801209] [Cited by in Crossref: 752] [Cited by in F6Publishing: 270] [Article Influence: 53.7] [Reference Citation Analysis]
Number Citing Articles
1 Romano TG, Schmidtbauer I, Silva FM, Pompilio CE, D'Albuquerque LA, Macedo E. Role of MELD score and serum creatinine as prognostic tools for the development of acute kidney injury after liver transplantation. PLoS One. 2013;8:e64089. [PMID: 23717537 DOI: 10.1371/journal.pone.0064089] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
2 Pedersen JS, Bendtsen F, Møller S. Management of cirrhotic ascites. Ther Adv Chronic Dis 2015;6:124-37. [PMID: 25954497 DOI: 10.1177/2040622315580069] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
3 Wang W, Liu Z, Qian J, Xu J, Que S, Zhuang L, Geng L, Zhou L, Zheng S. Systematic Assessment of Safety Threshold for Donor Age in Cadaveric Liver Transplantation. Front Med (Lausanne) 2021;8:596552. [PMID: 33748155 DOI: 10.3389/fmed.2021.596552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bruns H, Lozanovski VJ, Schultze D, Hillebrand N, Hinz U, Büchler MW, Schemmer P. Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: a multivariate analysis. PLoS One. 2014;9:e98782. [PMID: 24905210 DOI: 10.1371/journal.pone.0098782] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
5 Jaurigue MM, Cappell MS. Therapy for alcoholic liver disease. World J Gastroenterol 2014; 20(9): 2143-2158 [PMID: 24605013 DOI: 10.3748/wjg.v20.i9.2143] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
6 Frangakis C, Geschwind JF, Kim D, Chen Y, Koteish A, Hong K, Liapi E, Georgiades CS. Chemoembolization decreases drop-off risk of hepatocellular carcinoma patients on the liver transplant list. Cardiovasc Intervent Radiol. 2011;34:1254-1261. [PMID: 21191590 DOI: 10.1007/s00270-010-0077-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
7 Torp N, Israelsen M, Madsen B, Lutz P, Jansen C, Strassburg C, Mortensen C, Knudsen AW, Sorensen GL, Holmskov U, Schlosser A, Thiele M, Trebicka J, Krag A. Corrigendum to 'Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis' [JHEP Reports 3 (2021) 100287]. JHEP Rep 2021;3:100353. [PMID: 34693237 DOI: 10.1016/j.jhepr.2021.100353] [Reference Citation Analysis]
8 Wedd J, Bambha KM, Stotts M, Laskey H, Colmenero J, Gralla J, Biggins SW. Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation. Liver Transpl. 2014;20:1193-1201. [PMID: 24916539 DOI: 10.1002/lt.23929] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
9 Addepally NS, George N, Martinez-Macias R, Garcia-Saenz-de-Sicilia M, Kim WR, Duarte-Rojo A. Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis. Dig Dis Sci. 2018;63:3498-3508. [PMID: 30159733 DOI: 10.1007/s10620-018-5265-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Ho SY, Liu PH, Hsu CY, Hsia CY, Su CW, Lee YH, Huang YH, Lee FY, Hou MC, Huo TI. Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection. Sci Rep. 2018;8:4773. [PMID: 29555927 DOI: 10.1038/s41598-018-22923-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
11 Allegretti AS, Vela Parada X, Ortiz GA, Long J, Krinsky S, Zhao S, Fuchs BC, Sojoodi M, Zhang D, Karumanchi SA, Kalim S, Nigwekar SU, Thadhani RI, Parikh SM, Chung RT. Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis. Hepatology. 2019;69:729-741. [PMID: 30141205 DOI: 10.1002/hep.30230] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
12 Torp N, Israelsen M, Madsen B, Lutz P, Jansen C, Strassburg C, Mortensen C, Knudsen AW, Sorensen GL, Holmskov U, Schlosser A, Thiele M, Trebicka J, Krag A. Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis. JHEP Rep 2021;3:100287. [PMID: 34041469 DOI: 10.1016/j.jhepr.2021.100287] [Reference Citation Analysis]
13 Coppel S, Mathur K, Ekser B, Patidar KR, Orman E, Desai AP, Vilar-Gomez E, Kubal C, Chalasani N, Nephew L, Ghabril M. Extra-hepatic comorbidity burden significantly increases 90-day mortality in patients with cirrhosis and high model for endstage liver disease. BMC Gastroenterol 2020;20:302. [PMID: 32938387 DOI: 10.1186/s12876-020-01448-z] [Reference Citation Analysis]
14 Siciliano M, Parlati L, Maldarelli F, Rossi M, Ginanni Corradini S. Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther 2012; 3(4): 49-61 [PMID: 22966483 DOI: 10.4292/wjgpt.v3.i4.49] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
15 Huang H, Mai Z, Chen L, Li Q, Chen S, Bao K, Tang R, Wei W, Yu Y, Huang Z, Lai W, Wang B, Tan N, Chen J, Liu J, Liu Y. Prevalence and Mortality of Hypochloremia Among Patients with Coronary Artery Disease: A Cohort Study. Risk Manag Healthc Policy 2021;14:3137-45. [PMID: 34349574 DOI: 10.2147/RMHP.S306125] [Reference Citation Analysis]
16 Chirapongsathorn S, Krittanawong C, Enders FT, Pendegraft R, Mara KC, Borah BJ, Visscher SL, Loftus CG, Shah VH, Talwalkar JA, Kamath PS. Incidence and cost analysis of hospital admission and 30-day readmission among patients with cirrhosis. Hepatol Commun. 2018;2:188-198. [PMID: 29404526 DOI: 10.1002/hep4.1137] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
17 Papastergiou V, Tsochatzis EA, Pieri G, Thalassinos E, Dhar A, Bruno S, Karatapanis S, Luong TV, O'Beirne J, Patch D, Thorburn D, Burroughs AK. Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther 2014;39:721-32. [PMID: 24612165 DOI: 10.1111/apt.12654] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
18 Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, Baracos VE, Sawyer MB, Pang JX, Beaumont C, Esfandiari N, Myers RP. Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis. Clin Transl Gastroenterol 2015;6:e102. [PMID: 26181291 DOI: 10.1038/ctg.2015.31] [Cited by in Crossref: 155] [Cited by in F6Publishing: 138] [Article Influence: 22.1] [Reference Citation Analysis]
19 Cimen S, Guler S, Ayloo S, Molinari M. Implications of Hyponatremia in Liver Transplantation. J Clin Med 2014;4:66-74. [PMID: 26237018 DOI: 10.3390/jcm4010066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Kim M, Liotta EM, Maas MB, Braun RI, Garcia-Canga B, Ganger DR, Ladner DP, Reid KJ, Zee PC. Rest-activity rhythm disturbance in liver cirrhosis and association with cognitive impairment. Sleep 2021;44:zsaa288. [PMID: 33367862 DOI: 10.1093/sleep/zsaa288] [Reference Citation Analysis]
21 Kim HY, Choi JY, Park CH, Song MJ, Song DS, Kim CW, Bae SH, Yoon SK, Lee YJ, Rha SE. Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis. J Gastroenterol. 2013;48:1180-1187. [PMID: 23354621 DOI: 10.1007/s00535-012-0740-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
22 Du SD, Che L, Mao YL. Liver function assessment: Application and improvement in clinical practice. Shijie Huaren Xiaohua Zazhi 2012; 20(27): 2549-2553 [DOI: 10.11569/wcjd.v20.i27.2549] [Reference Citation Analysis]
23 Usala RL, Fernandez SJ, Mete M, Cowen L, Shara NM, Barsony J, Verbalis JG. Hyponatremia Is Associated With Increased Osteoporosis and Bone Fractures in a Large US Health System Population. J Clin Endocrinol Metab 2015;100:3021-31. [PMID: 26083821 DOI: 10.1210/jc.2015-1261] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 8.7] [Reference Citation Analysis]
24 Brock GN, Washburn K, Marvin MR. Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing. PLoS One 2019;14:e0223053. [PMID: 31581270 DOI: 10.1371/journal.pone.0223053] [Reference Citation Analysis]
25 Kondo T, Maruyama H, Sekimoto T, Shimada T, Takahashi M, Yokosuka O. Reversed portal flow: Clinical influence on the long-term outcomes in cirrhosis. World J Gastroenterol 2015; 21(29): 8894-8902 [PMID: 26269679 DOI: 10.3748/wjg.v21.i29.8894] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
26 Liu J, Li H, Xia J, Wang X, Huang Y, Li B, Meng Z, Gao Y, Qian Z, Liu F, Lu X, Liu J, Deng G, Zheng Y, Yan H, Qiao L, Xiang X, Zhang Q, Chen R, Chen J, Luo S, Gao, Ji L, Li J, Zhou X, Ren H, Lu S, Li S, Zhang W, Zheng X. Baseline Neutrophil-to-Lymphocyte Ratio Is Independently Associated With 90-Day Transplant-Free Mortality in Patients With Cirrhosis. Front Med (Lausanne) 2021;8:726950. [PMID: 34532334 DOI: 10.3389/fmed.2021.726950] [Reference Citation Analysis]
27 Wang R, Qi X, Guo X. Quantification of ascites based on abdomino-pelvic computed tomography scans for predicting the in-hospital mortality of liver cirrhosis. Exp Ther Med 2017;14:5733-42. [PMID: 29285115 DOI: 10.3892/etm.2017.5321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
28 Asrani SK, Simonetto DA, Kamath PS. Acute-on-Chronic Liver Failure. Clin Gastroenterol Hepatol 2015;13:2128-39. [PMID: 26188138 DOI: 10.1016/j.cgh.2015.07.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
29 Arase Y, Kagawa T, Tsuruya K, Sato H, Teramura E, Anzai K, Hirose S, Deguchi R, Shiraishi K, Mine T. Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites. Clin Drug Investig 2019;39:45-54. [PMID: 30284699 DOI: 10.1007/s40261-018-0714-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
30 Aby ES, Lake JR. Basic principles of liver allocation and development over the years. Curr Opin Organ Transplant 2020;25:99-103. [PMID: 32073495 DOI: 10.1097/MOT.0000000000000732] [Reference Citation Analysis]
31 Annamalai A, Harada MY, Chen M, Tran T, Ko A, Ley EJ, Nuno M, Klein A, Nissen N, Noureddin M. Predictors of Mortality in the Critically Ill Cirrhotic Patient: Is the Model for End-Stage Liver Disease Enough? J Am Coll Surg 2017;224:276-82. [PMID: 27887981 DOI: 10.1016/j.jamcollsurg.2016.11.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
32 Reiss KA, Yu S, Mamtani R, Mehta R, D'Addeo K, Wileyto EP, Taddei TH, Kaplan DE. Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study. J Clin Oncol 2017;35:3575-81. [PMID: 28872925 DOI: 10.1200/JCO.2017.73.8245] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 9.6] [Reference Citation Analysis]
33 Abdel-Wahab R, Hassan MM, George B, Carmagnani Pestana R, Xiao L, Lacin S, Yalcin S, Shalaby AS, Al-Shamsi HO, Raghav K, Wolff RA, Yao JC, Girard L, Haque A, Duda DG, Dima S, Popescu I, Elghazaly HA, Vauthey JN, Aloia TA, Tzeng CW, Chun YS, Rashid A, Morris JS, Amin HM, Kaseb AO. Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients. Oncology 2020;98:836-46. [PMID: 33027788 DOI: 10.1159/000502482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Asrani SK, Kim WR. Organ allocation for chronic liver disease: model for end-stage liver disease and beyond. Curr Opin Gastroenterol 2010;26:209-13. [PMID: 20224394 DOI: 10.1097/MOG.0b013e32833867d8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
35 Pozo-Laderas JC, Rodríguez-Perálvarez M, Muñoz-Villanueva MC, Rivera-Espinar F, Durban-García I, Muñoz-Trujillo J, Robles-Arista JC, Briceño-Delgado J. Pretransplant predictors of early mortality in adult recipients of liver transplantation in the MELD-Na Era. Med Intensiva (Engl Ed) 2019;43:261-9. [PMID: 29735173 DOI: 10.1016/j.medin.2018.03.008] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Tapper EB, Nikirk S, Parikh ND, Zhao L. Falls are common, morbid, and predictable in patients with cirrhosis. J Hepatol 2021;75:582-8. [PMID: 33887359 DOI: 10.1016/j.jhep.2021.04.012] [Reference Citation Analysis]
37 Cárdenas A, Solà E, Rodríguez E, Barreto R, Graupera I, Pavesi M, Saliba F, Welzel TM, Martinez-Gonzalez J, Gustot T. Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study. Crit Care. 2014;18:700. [PMID: 25643318 DOI: 10.1186/s13054-014-0700-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
38 Kwo PY. Management of Hyponatremia in Clinical Hepatology Practice. Curr Gastroenterol Rep 2014;16. [DOI: 10.1007/s11894-014-0382-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
39 Case JJ, Khan N, Delrahim M, Dizdarevic J, Nichols DJ, Schreiber MA, Deloughery TG, Khan A. Association of Massive Transfusion for Resuscitation in Gastrointestinal Bleeding with Transfusion-related Acute Lung Injury. Indian J Crit Care Med 2017;21:506-13. [PMID: 28904480 DOI: 10.4103/ijccm.IJCCM_380_16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
40 Bernardi M, Zaccherini G. Approach and management of dysnatremias in cirrhosis. Hepatol Int. 2018;12:487-499. [PMID: 30203382 DOI: 10.1007/s12072-018-9894-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
41 Lange UG, Bucher JN, Schoenberg MB, Benzing C, Schmelzle M, Gradistanac T, Strocka S, Hau HM, Bartels M. Orthotopic liver transplantation for giant liver haemangioma: A case report. World J Transplant 2015; 5(4): 354-359 [PMID: 26722664 DOI: 10.5500/wjt.v5.i4.354] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
42 Renfrew PD, Quan H, Doig CJ, Dixon E, Molinari M. The Model for End-stage Liver Disease accurately predicts 90-day liver transplant wait-list mortality in Atlantic Canada. Can J Gastroenterol 2011;25:359-64. [PMID: 21876856 DOI: 10.1155/2011/454727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
43 Kalra A, Wedd JP, Bambha KM, Gralla J, Golden-Mason L, Collins C, Rosen HR, Biggins SW. Neutrophil-to-lymphocyte ratio correlates with proinflammatory neutrophils and predicts death in low model for end-stage liver disease patients with cirrhosis. Liver Transpl. 2017;23:155-165. [PMID: 28006875 DOI: 10.1002/lt.24702] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 8.4] [Reference Citation Analysis]
44 Thandassery RB, Montano-Loza AJ. Role of Nutrition and Muscle in Cirrhosis. Curr Treat Options Gastroenterol. 2016;14:257-273. [PMID: 27023701 DOI: 10.1007/s11938-016-0093-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
45 Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet 2021;398:1359-76. [PMID: 34543610 DOI: 10.1016/S0140-6736(21)01374-X] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
46 Corona G, Giuliani C, Parenti G, Norello D, Verbalis JG, Forti G, Maggi M, Peri A. Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis. PLoS One 2013;8:e80451. [PMID: 24367479 DOI: 10.1371/journal.pone.0080451] [Cited by in Crossref: 145] [Cited by in F6Publishing: 110] [Article Influence: 16.1] [Reference Citation Analysis]
47 Lee H, Yoon S, Oh SY, Shin J, Kim J, Jung CW, Ryu HG. Comparison of APACHE IV with APACHE II, SAPS 3, MELD, MELD-Na, and CTP scores in predicting mortality after liver transplantation. Sci Rep 2017;7:10884. [PMID: 28883401 DOI: 10.1038/s41598-017-07797-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Grąt M, Wronka KM, Patkowski W, Stypułkowski J, Grąt K, Krasnodębski M, Masior Ł, Lewandowski Z, Krawczyk M. Effects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient Status. Dig Dis Sci 2016;61:626-35. [PMID: 26499986 DOI: 10.1007/s10620-015-3910-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
49 Girault-Sotias PE, Gerbier R, Flahault A, de Mota N, Llorens-Cortes C. Apelin and Vasopressin: The Yin and Yang of Water Balance. Front Endocrinol (Lausanne) 2021;12:735515. [PMID: 34880830 DOI: 10.3389/fendo.2021.735515] [Reference Citation Analysis]
50 Somsouk M, To’o K, Ali M, Vittinghoff E, Yeh BM, Yee J, Monto A, Inadomi JM, Aslam R. Esophageal varices on computed tomography and subsequent variceal hemorrhage. Abdom Imaging. 2014;39:251-256. [PMID: 24366107 DOI: 10.1007/s00261-013-0057-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
51 Bittermann T, Makar G, Goldberg DS. Early post-transplant survival: Interaction of MELD score and hospitalization status. J Hepatol. 2015;63:601-608. [PMID: 25858520 DOI: 10.1016/j.jhep.2015.03.034] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
52 Allegretti AS, Ortiz G, Kalim S, Wibecan J, Zhang D, Shan HY, Xu D, Chung RT, Karumanchi SA, Thadhani RI. Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury. Dig Dis Sci 2016;61:3609-20. [PMID: 27655105 DOI: 10.1007/s10620-016-4316-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
53 Crawford DH, Stuart K. Adding serum sodium to model for end-stage liver disease: identifying those most at risk. J Gastroenterol Hepatol 2009;24:1804-6. [PMID: 20002937 DOI: 10.1111/j.1440-1746.2009.06028.x] [Reference Citation Analysis]
54 Fallet E, Rayar M, Landrieux A, Camus C, Houssel-Debry P, Jezequel C, Legros L, Uguen T, Ropert-Bouchet M, Boudjema K, Guyader D, Bardou-Jacquet E. Iron metabolism imbalance at the time of listing increases overall and infectious mortality after liver transplantation. World J Gastroenterol 2020; 26(16): 1938-1949 [PMID: 32390704 DOI: 10.3748/wjg.v26.i16.1938] [Reference Citation Analysis]
55 Reig M, Forner A, Rimola J, Ferrer-Fábrega J, Burrel M, Garcia-Criado A, Kelley RK, Galle PR, Mazzaferro V, Salem R, Sangro B, Singal AG, Vogel A, Fuster J, Ayuso C, Bruix J. BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update. J Hepatol 2021:S0168-8278(21)02223-6. [PMID: 34801630 DOI: 10.1016/j.jhep.2021.11.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
56 Tapper EB, Zhang P, Garg R, Nault T, Leary K, Krishnamurthy V, Su GL. Body composition predicts mortality and decompensation in compensated cirrhosis patients: A prospective cohort study. JHEP Rep 2020;2:100061. [PMID: 32039402 DOI: 10.1016/j.jhepr.2019.11.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
57 McKie PM, Cataliotti A, Lahr BD, Martin FL, Redfield MM, Bailey KR, Rodeheffer RJ, Burnett JC. The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects. J Am Coll Cardiol. 2010;55:2140-2147. [PMID: 20447539 DOI: 10.1016/j.jacc.2010.01.031] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 7.2] [Reference Citation Analysis]
58 Liao S, Lu X, Cheang I, Zhu X, Yin T, Yao W, Zhang H, Li X. Prognostic value of the modified model for end-stage liver disease (MELD) score including albumin in acute heart failure. BMC Cardiovasc Disord 2021;21:128. [PMID: 33750318 DOI: 10.1186/s12872-021-01941-7] [Reference Citation Analysis]
59 Ruf A, Dirchwolf M, Freeman RB. From Child-Pugh to MELD score and beyond: Taking a walk down memory lane. Ann Hepatol 2021;27:100535. [PMID: 34560316 DOI: 10.1016/j.aohep.2021.100535] [Reference Citation Analysis]
60 Fedosina EA, Byeverov AO, Bogomolov PO, Staroverova NP. [Some practical issues in the management of patients with decompensated liver cirrhosis]. Ter Arkh 2019;91:148-54. [PMID: 32598767 DOI: 10.26442/00403660.2019.08.000391] [Reference Citation Analysis]
61 Pereira R, Buglevski M, Perdigoto R, Marcelino P, Saliba F, Blot S, Starkopf J. Intra-abdominal hypertension and abdominal compartment syndrome in the critically ill liver cirrhotic patient-prevalence and clinical outcomes. A multicentric retrospective cohort study in intensive care. PLoS One 2021;16:e0251498. [PMID: 33984016 DOI: 10.1371/journal.pone.0251498] [Reference Citation Analysis]
62 Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman R, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure. Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis. J Clin Exp Hepatol 2020;10:339-76. [PMID: 32655238 DOI: 10.1016/j.jceh.2020.04.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
63 Sussman AN, Boyer TD. Management of refractory ascites and hepatorenal syndrome. Curr Gastroenterol Rep 2011;13:17-25. [PMID: 21080246 DOI: 10.1007/s11894-010-0156-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
64 Samuel D, Coilly A. Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation. BMC Med 2018;16:113. [PMID: 30064414 DOI: 10.1186/s12916-018-1110-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
65 Badawy A, Kaido T, Hamaguchi Y, Anazawa T, Yagi S, Fukumitsu K, Kamo N, Okajima H, Uemoto S. Is Muscle MELD a More Promising Predictor for Mortality After Living Donor Liver Transplantation? Prog Transplant 2018;28:213-9. [PMID: 29902957 DOI: 10.1177/1526924818781571] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Kinny-Köster B, Bartels M, Becker S, Scholz M, Thiery J, Ceglarek U, Kaiser T. Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease. PLoS One 2016;11:e0159205. [PMID: 27410482 DOI: 10.1371/journal.pone.0159205] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
67 Koola JD, Ho S, Chen G, Perkins AM, Cao A, Davis SE, Matheny ME. Development of a national Department of Veterans Affairs mortality risk prediction model among patients with cirrhosis. BMJ Open Gastroenterol 2019;6:e000342. [PMID: 31875140 DOI: 10.1136/bmjgast-2019-000342] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Jin JY, Zheng YB, Zheng J, Liu J, Mao YJ, Chen SG, Gao ZL, Zheng RQ. 2D shear wave elastography combined with MELD improved prognostic accuracy in patients with acute-on-chronic hepatitis B liver failure. Eur Radiol 2018;28:4465-74. [PMID: 29696433 DOI: 10.1007/s00330-018-5336-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
69 Lau T, Ahmad J. Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine. Hepat Med. 2013;5:1-10. [PMID: 24696621 DOI: 10.2147/hmer.s9049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
70 Mindikoglu AL, Opekun AR, Putluri N, Devaraj S, Sheikh-Hamad D, Vierling JM, Goss JA, Rana A, Sood GK, Jalal PK, Inker LA, Mohney RP, Tighiouart H, Christenson RH, Dowling TC, Weir MR, Seliger SL, Hutson WR, Howell CD, Raufman JP, Magder LS, Coarfa C. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res 2018;195:25-47. [PMID: 29291380 DOI: 10.1016/j.trsl.2017.12.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
71 Kwong AJ, Lai JC, Dodge JL, Roberts JP. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score. Liver Transpl 2015;21:1403-9. [PMID: 26289624 DOI: 10.1002/lt.24307] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
72 Waikar SS, Curhan GC, Brunelli SM. Mortality associated with low serum sodium concentration in maintenance hemodialysis. Am J Med. 2011;124:77-84. [PMID: 21187188 DOI: 10.1016/j.amjmed.2010.07.029] [Cited by in Crossref: 99] [Cited by in F6Publishing: 86] [Article Influence: 9.0] [Reference Citation Analysis]
73 Kc M, Olson APJ, Wang Q, Lim N. Unexpected clinical outcomes following the implementation of a standardised order set for hepatic encephalopathy. BMJ Open Gastroenterol 2021;8:e000621. [PMID: 33866310 DOI: 10.1136/bmjgast-2021-000621] [Reference Citation Analysis]
74 Pinter M, Trauner M, Peck-Radosavljevic M, Sieghart W. Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open. 2016;1:e000042. [PMID: 27843598 DOI: 10.1136/esmoopen-2016-000042] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 18.0] [Reference Citation Analysis]
75 Guo Z, He X, Wu L, Ju W, Hu A, Tai Q, Wang D, Ma Y, Wang G, Zhu X. Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients. Surg Today. 2010;40:38-45. [PMID: 20037838 DOI: 10.1007/s00595-009-4114-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
76 Nitsch J, Sack J, Halle MW, Moltz JH, Wall A, Rutherford AE, Kikinis R, Meine H. MRI-based radiomic feature analysis of end-stage liver disease for severity stratification. Int J Comput Assist Radiol Surg 2021;16:457-66. [PMID: 33646521 DOI: 10.1007/s11548-020-02295-9] [Reference Citation Analysis]
77 Asrani SK, Kamath PS. Model for end-stage liver disease score and MELD exceptions: 15 years later. Hepatol Int. 2015;9:346-354. [PMID: 26016462 DOI: 10.1007/s12072-015-9631-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
78 Cullaro G, Sarkar M, Lai JC. Sex-based disparities in delisting for being "too sick" for liver transplantation. Am J Transplant. 2018;18:1214-1219. [PMID: 29194969 DOI: 10.1111/ajt.14608] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
79 Yang SM, Choi SN, Yu JH, Yoon HK, Kim WH, Jung CW, Suh KS, Lee KH. Intraoperative hyponatremia is an independent predictor of one-year mortality after liver transplantation. Sci Rep 2018;8:18023. [PMID: 30575797 DOI: 10.1038/s41598-018-37006-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
80 Berni ER, Jones BI, Berni TR, Whitehouse J, Hudson M, Orr J, Conway P, Amlani B, Currie CJ. The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC). PLoS One 2019;14:e0223253. [PMID: 31581237 DOI: 10.1371/journal.pone.0223253] [Reference Citation Analysis]
81 Allegretti AS, Frenk NE, Li DK, Seethapathy H, Vela Parada XF, Long J, Endres P, Pratt DS, Chung RT, Ganguli S, Irani Z, Yamada K. Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement. PLoS One 2019;14:e0217442. [PMID: 31120995 DOI: 10.1371/journal.pone.0217442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
82 Latt NL, Niazi M, Pyrsopoulos NT. Liver transplant allocation policies and outcomes in United States: A comprehensive review. World J Methodol 2022; 12(1): 32-42 [DOI: 10.5662/wjm.v12.i1.32] [Reference Citation Analysis]
83 Corona G, Giuliani C, Verbalis JG, Forti G, Maggi M, Peri A. Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis. PLoS One 2015;10:e0124105. [PMID: 25905459 DOI: 10.1371/journal.pone.0124105] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 8.4] [Reference Citation Analysis]
84 Orman ES, Johnson AW, Ghabril M, Sachs GA. Hospice care for end stage liver disease in the United States. Expert Rev Gastroenterol Hepatol 2021;15:797-809. [PMID: 33599185 DOI: 10.1080/17474124.2021.1892487] [Reference Citation Analysis]
85 Casellas-Robert M, Lim C, Lopez-Ben S, Lladó L, Salloum C, Codina-Font J, Comas-Cufí M, Ramos E, Figueras J, Azoulay D. Laparoscopic Liver Resection for Hepatocellular Carcinoma in Child-Pugh A Patients With and Without Portal Hypertension: A Multicentre Study. World J Surg 2020;44:3915-22. [PMID: 32661688 DOI: 10.1007/s00268-020-05687-9] [Reference Citation Analysis]
86 Wiering L, Sponholz F, Brandl A, Dziodzio T, Jara M, Dargie R, Eurich D, Schmelzle M, Sauer IM, Aigner F, Kotsch K, Pratschke J, Öllinger R, Ritschl PV. Perioperative Pleural Drainage in Liver Transplantation: A Retrospective Analysis from a High-Volume Liver Transplant Center. Ann Transplant 2020;25:e918456. [PMID: 31949125 DOI: 10.12659/AOT.918456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
87 Sansoè G, Aragno M, Mastrocola R, Parola M. Pathogenesis of solute-free water retention in experimental ascitic cirrhosis: is vasopressin the only culprit? Clin Sci (Lond) 2016;130:117-24. [PMID: 26519424 DOI: 10.1042/CS20150479] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
88 Guo H, Wu LJ, Jin Z, Li XZ, Jin JJ. Vasopressin V2-receptor antagonist tolvaptan for treating cirrhotic patients with hyponatremia and hepatic edema: A systemic review. Shijie Huaren Xiaohua Zazhi 2016; 24(6): 938-946 [DOI: 10.11569/wcjd.v24.i6.938] [Reference Citation Analysis]
89 Atiemo K, Skaro A, Maddur H, Zhao L, Montag S, VanWagner L, Goel S, Kho A, Ho B, Kang R, Holl JL, Abecassis MM, Levitsky J, Ladner DP. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data. Am J Transplant 2017;17:2410-9. [PMID: 28226199 DOI: 10.1111/ajt.14239] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
90 Freitas ACT, Rampim AT, Nunes CP, Coelho JCU. IMPACT OF MELD SODIUM ON LIVER TRANSPLANTATION WAITING LIST. Arq Bras Cir Dig 2019;32:e1460. [PMID: 31826087 DOI: 10.1590/0102-672020190001e1460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
91 Wagner J, Garcia-Rodriguez V, Yu A, Dutra B, Bhatt A, Larson S, Farooq A. The Model for End-Stage Liver Disease-Sodium Score at Admission Is Prognostic of Covid-19 Disease Severity. SN Compr Clin Med 2020;:1-5. [PMID: 33015551 DOI: 10.1007/s42399-020-00534-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Zhang M, Yin F, Chen B, Li YP, Yan LN, Wen TF, Li B. Pretransplant prediction of posttransplant survival for liver recipients with benign end-stage liver diseases: a nonlinear model. PLoS One 2012;7:e31256. [PMID: 22396731 DOI: 10.1371/journal.pone.0031256] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
93 Huang KC, Tsai YH, Huang KC, Lee MS. Model for end-stage liver disease (MELD) score as a predictor and monitor of mortality in patients with Vibrio vulnificus necrotizing skin and soft tissue infections. PLoS Negl Trop Dis 2015;9:e0003720. [PMID: 25923115 DOI: 10.1371/journal.pntd.0003720] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
94 Sun J, Guo H, Yu X, Zhu H, Zhang X, Yang J, Wang J, Qian Z, Shen Z, Mao R, Zhang J. A neutrophil-to-lymphocyte ratio-based prognostic model to predict mortality in patients with HBV-related acute-on-chronic liver failure. BMC Gastroenterol 2021;21:422. [PMID: 34758747 DOI: 10.1186/s12876-021-02007-w] [Reference Citation Analysis]
95 Lee BT, Yang AH, Urban S, Kim KY, Ter-Oganesyan R, Yuan L, Han HH, Khemichian S, Kahn JA, Kim B. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures. Eur J Gastroenterol Hepatol 2021;33:541-6. [PMID: 32398491 DOI: 10.1097/MEG.0000000000001760] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Neeff H, Mariaskin D, Spangenberg HC, Hopt UT, Makowiec F. Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using Child and MELD scores. J Gastrointest Surg. 2011;15:1-11. [PMID: 21061184 DOI: 10.1007/s11605-010-1366-9] [Cited by in Crossref: 107] [Cited by in F6Publishing: 74] [Article Influence: 9.7] [Reference Citation Analysis]
97 Sugiyama C, Akai A, Yamakita N, Ikeda T, Yasuda K. Muscle hematoma: A critically important complication of alcoholic liver cirrhosis. World J Gastroenterol 2009; 15(35): 4457-4460 [PMID: 19764102 DOI: 10.3748/wjg.15.4457] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
98 Picon RV, Bertol FS, Tovo CV, de Mattos AZ. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients. World J Gastroenterol 2017; 23(28): 5237-5245 [PMID: 28811718 DOI: 10.3748/wjg.v23.i28.5237] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
99 Cheng Y, Wei GQ, Cai QC, Jiang Y, Wu AP. Prognostic Value of Model for End-Stage Liver Disease Incorporating with Serum Sodium Score for Development of Acute Kidney Injury after Liver Transplantation. Chin Med J (Engl) 2018;131:1314-20. [PMID: 29786044 DOI: 10.4103/0366-6999.232798] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 Magder LS, Regev A, Mindikoglu AL. Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list. Transpl Int. 2012;25:409-415. [PMID: 22299756 DOI: 10.1111/j.1432-2277.2012.01431.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
101 Gameiro J, Agapito Fonseca J, Monteiro Dias J, Melo MJ, Jorge S, Velosa J, Lopes JA. Prediction of acute kidney injury in cirrhotic patients: a new score combining renal, liver and inflammatory markers. Int J Nephrol Renovasc Dis 2018;11:149-54. [PMID: 29731657 DOI: 10.2147/IJNRD.S163602] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
102 Kim TY, Song DS, Kim HY, Sinn DH, Yoon EL, Kim CW, Jung YK, Suk KT, Lee SS, Lee CH, Kim TH, Kim JH, Choe WH, Yim HJ, Kim SE, Baik SK, Lee BS, Jang JY, Suh J 3rd, Kim HS, Nam SW, Kwon HC, Kim YS, Kim SG, Chae HB, Yang JM, Sohn JH, Lee HJ, Park SH, Han BH, Choi EH, Kim CH, Kim DJ; Korean Acute-on-Chronic Liver Failure Study Group. Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition. PLoS One 2016;11:e0146745. [PMID: 26789409 DOI: 10.1371/journal.pone.0146745] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
103 Grodin JL, Gallup D, Anstrom KJ, Felker GM, Chen HH, Tang WHW. Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF). Am J Cardiol 2017;119:2003-9. [PMID: 28433216 DOI: 10.1016/j.amjcard.2017.03.031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
104 Ahluwalia V, Wade JB, Thacker L, Kraft KA, Sterling RK, Stravitz RT, Fuchs M, Bouneva I, Puri P, Luketic V, Sanyal AJ, Gilles H, Heuman DM, Bajaj JS. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis. J Hepatol. 2013;59:467-473. [PMID: 23665182 DOI: 10.1016/j.jhep.2013.04.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
105 Sbardella E, Isidori AM, Arnaldi G, Arosio M, Barone C, Benso A, Berardi R, Capasso G, Caprio M, Ceccato F, Corona G, Della Casa S, De Nicola L, Faustini-Fustini M, Fiaccadori E, Gesualdo L, Gori S, Lania A, Mantovani G, Menè P, Parenti G, Pinto C, Pivonello R, Razzore P, Regolisti G, Scaroni C, Trepiccione F, Lenzi A, Peri A; the: Fluid and Electrolyte Disorders Club of the Italian Society of Endocrinology; Italian Society of Nephrology; and Italian Association of Medical Oncology. Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM). J Endocrinol Invest 2018;41:3-19. [PMID: 29152673 DOI: 10.1007/s40618-017-0776-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
106 Jurado-García J, Muñoz García-Borruel M, Rodríguez-Perálvarez ML, Ruíz-Cuesta P, Poyato-González A, Barrera-Baena P, Fraga-Rivas E, Costán-Rodero G, Briceño-Delgado J, Montero-Álvarez JL, de la Mata-García M. Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality. PLoS One 2016;11:e0155822. [PMID: 27299728 DOI: 10.1371/journal.pone.0155822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
107 Xue R, Duan Z, Liu H, Chen L, Yu H, Ren M, Zhu Y, Jin C, Han T, Gao Z, Meng Q. A novel dynamic model for predicting outcome in patients with hepatitis B virus related acute-on-chronic liver failure. Oncotarget. 2017;8:108970-108980. [PMID: 29312583 DOI: 10.18632/oncotarget.22447] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
108 Ko JS, Byun J, Park S, Woo JY. Prediction of insufficient hepatic enhancement during the Hepatobiliary phase of Gd-EOB DTPA-enhanced MRI using machine learning classifier and feature selection algorithms. Abdom Radiol (NY) 2021. [PMID: 34647145 DOI: 10.1007/s00261-021-03308-0] [Reference Citation Analysis]
109 Simonetti RG, Perricone G, Nikolova D, Bjelakovic G, Gluud C. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis. Cochrane Database Syst Rev 2019;6:CD004039. [PMID: 31251387 DOI: 10.1002/14651858.CD004039.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
110 Piano S, Tonon M, Angeli P. Management of ascites and hepatorenal syndrome. Hepatol Int 2018;12:122-34. [DOI: 10.1007/s12072-017-9815-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 7.2] [Reference Citation Analysis]
111 Radisavljevic MM, Bjelakovic GB, Nagorni AV, Stojanovic MP, Radojkovicn MD, Jovic JZ, Ignjatovic AM, Radisavljevic MM, Simonovic MM. Predictors of Mortality in Long-Term Follow-Up of Patients with Terminal Alcoholic Cirrhosis: Is It Time to Accept Remodeled Scores? Med Princ Pract. 2017;26:169-175. [PMID: 27676412 DOI: 10.1159/000451057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
112 Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. BMC Gastroenterol 2009;9:72. [PMID: 19778459 DOI: 10.1186/1471-230X-9-72] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
113 Greenberg A, Verbalis JG, Amin AN, Burst VR, Chiodo JA 3rd, Chiong JR, Dasta JF, Friend KE, Hauptman PJ, Peri A, Sigal SH. Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int 2015;88:167-77. [PMID: 25671764 DOI: 10.1038/ki.2015.4] [Cited by in Crossref: 92] [Cited by in F6Publishing: 70] [Article Influence: 13.1] [Reference Citation Analysis]
114 Bezinover D, Nahouraii L, Sviatchenko A, Wang M, Kimatian S, Saner FH, Stine JG. Hyponatremia Is Associated With Increased Mortality in Children on the Waiting List for Liver Transplantation. Transplant Direct 2020;6:e604. [PMID: 33134484 DOI: 10.1097/TXD.0000000000001050] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Lim YS, Larson TS, Benson JT, Kamath PS, Kremers WK, Therneau TM, Kim WR. Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol. 2010;52:523-528. [PMID: 20185195 DOI: 10.1016/j.jhep.2010.01.009] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
116 Aithal GP, Palaniyappan N, China L, Härmälä S, Macken L, Ryan JM, Wilkes EA, Moore K, Leithead JA, Hayes PC, O'Brien AJ, Verma S. Guidelines on the management of ascites in cirrhosis. Gut 2021;70:9-29. [PMID: 33067334 DOI: 10.1136/gutjnl-2020-321790] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
117 Berchtold L, Filzer A, Achermann R, Devetzis V, Dahdal S, Bonani M, Schnyder A, Golshayan D, Amico P, Huynh-Do U, de Seigneux S, Arampatzis S, On Behalf Of Swiss Transplant Cohort Study Collaborators. Impact of Hyponatremia after Renal Transplantation on Decline of Renal Function, Graft Loss and Patient Survival: A Prospective Cohort Study. Nutrients 2021;13:2995. [PMID: 34578871 DOI: 10.3390/nu13092995] [Reference Citation Analysis]
118 Bezinover D, Navabi S, Wang M, Li Z, William M, Stine JG. Hyponatremia Is Protective Against the Development of Portal Vein Thrombosis in Patients Undergoing Liver Transplant. Transplant Proc 2019;51:1880-6. [PMID: 31399172 DOI: 10.1016/j.transproceed.2019.05.014] [Reference Citation Analysis]
119 Paternostro R, Bardach C, Hofer BS, Scheiner B, Schwabl P, Asenbaum U, Ba-Ssalamah A, Scharitzer M, Bucscis T, Simbrunner B, Bauer D, Trauner M, Mandorfer M, Reiberger T, Lampichler K. Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension. Liver Int. 2021;41:799-809. [PMID: 33290614 DOI: 10.1111/liv.14758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
120 Trieu JA, Bilal M, Hmoud B. Factors associated with waiting time on the liver transplant list: an analysis of the United Network for Organ Sharing (UNOS) database. Ann Gastroenterol 2018;31:84-9. [PMID: 29333071 DOI: 10.20524/aog.2017.0217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
121 Zhang Y, Nie Y, Liu L, Zhu X. Assessing the prognostic scores for the prediction of the mortality of patients with acute-on-chronic liver failure: a retrospective study. PeerJ 2020;8:e9857. [PMID: 32983642 DOI: 10.7717/peerj.9857] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Hong G, Lee KW, Suh S, Yoo T, Kim H, Park MS, Choi Y, Yi NJ, Suh KS. The model for end-stage liver disease score-based system predicts short term mortality better than the current Child-Turcotte-Pugh score-based allocation system during waiting for deceased liver transplantation. J Korean Med Sci. 2013;28:1207-1212. [PMID: 23960449 DOI: 10.3346/jkms.2013.28.8.1207] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
123 Caly WR, Abreu RM, Bitelman B, Carrilho FJ, Ono SK. Clinical Features of Refractory Ascites in Outpatients. Clinics (Sao Paulo). 2017;72:405-410. [PMID: 28792999 DOI: 10.6061/clinics/2017(07)03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
124 Bannaga A, Arasaradnam RP. Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review. World J Gastroenterol 2020; 26(33): 5022-5049 [PMID: 32952347 DOI: 10.3748/wjg.v26.i33.5022] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
125 Gruttadauria S, Francesco FD, Vizzini GB, Luca A, Spada M, Cintorino D, Petri SL, Pietrosi G, Pagano D, Gridelli B. Early graft dysfunction following adult-to-adult living-related liver transplantation: Predictive factors and outcomes. World J Gastroenterol 2009; 15(36): 4556-4560 [PMID: 19777614 DOI: 10.3748/wjg.15.4556] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
126 Cullaro G, Rubin JB, Mehta N, Lai JC. Differential Impact of Age Among Liver Transplant Candidates With and Without Hepatocellular Carcinoma. Liver Transpl 2020;26:349-58. [PMID: 31610089 DOI: 10.1002/lt.25662] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
127 Alshuwaykh O, Kwong A, Goel A, Cheung A, Dhanasekaran R, Ahmed A, Daugherty T, Dronamraju D, Kumari R, Kim WR, Nguyen MH, Esquivel CO, Concepcion W, Melcher M, Bonham A, Pham T, Gallo A, Kwo PY. Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation. Hepatol Commun 2021;5:516-25. [PMID: 33681683 DOI: 10.1002/hep4.1644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
128 Cullaro G, Verna EC, Lai JC. Association Between Renal Function Pattern and Mortality in Patients With Cirrhosis. Clin Gastroenterol Hepatol 2019;17:2364-70. [PMID: 30716479 DOI: 10.1016/j.cgh.2019.01.043] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
129 Asrani SK, Kim WR. Model for end-stage liver disease: end of the first decade. Clin Liver Dis. 2011;15:685-698. [PMID: 22032523 DOI: 10.1016/j.cld.2011.08.009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
130 Sinjali K, Bent C. Massive duodenal variceal hemorrhage in a patient with prior Roux-en-Y gastric bypass. Radiol Case Rep 2021;16:3304-7. [PMID: 34484536 DOI: 10.1016/j.radcr.2021.08.002] [Reference Citation Analysis]
131 Goudsmit BFJ, Putter H, Tushuizen ME, Vogelaar S, Pirenne J, Alwayn IPJ, van Hoek B, Braat AE. Refitting the Model for End-Stage Liver Disease for the Eurotransplant Region. Hepatology 2021;74:351-63. [PMID: 33301607 DOI: 10.1002/hep.31677] [Reference Citation Analysis]
132 Attar B. Approach to Hyponatremia in Cirrhosis. Clin Liver Dis (Hoboken). 2019;13:98-101. [PMID: 31061701 DOI: 10.1002/cld.790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
133 Leise MD, Findlay JY. Hyponatremia in the perioperative period: When and how to correct. Clin Liver Dis (Hoboken) 2017;9:111-4. [PMID: 30992972 DOI: 10.1002/cld.630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
134 Cullaro G, Kim G, Pereira MR, Brown RS Jr, Verna EC. Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis. Dig Dis Sci. 2017;62:3487-3494. [PMID: 29098551 DOI: 10.1007/s10620-017-4804-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
135 Barakat AA, Metwaly AA, Nasr FM, El-Ghannam M, El-Talkawy MD, Taleb HA. Impact of hyponatremia on frequency of complications in patients with decompensated liver cirrhosis. Electron Physician 2015;7:1349-58. [PMID: 26516441 DOI: 10.14661/1349] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
136 Flahault A, Girault-Sotias PE, Keck M, Alvear-Perez R, De Mota N, Estéoulle L, Ramanoudjame SM, Iturrioz X, Bonnet D, Llorens-Cortes C. A metabolically stable apelin-17 analog decreases AVP-induced antidiuresis and improves hyponatremia. Nat Commun 2021;12:305. [PMID: 33436646 DOI: 10.1038/s41467-020-20560-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
137 Lv XH, Chen YS, Liu HB, Wang BY, Sun MJ, Song M. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis. Shijie Huaren Xiaohua Zazhi 2010; 18(29): 3084-3088 [DOI: 10.11569/wcjd.v18.i29.3084] [Reference Citation Analysis]
138 Locke JE, Shelton BA, Olthoff KM, Pomfret EA, Forde KA, Sawinski D, Gray M, Ascher NL. Quantifying Sex-Based Disparities in Liver Allocation. JAMA Surg 2020;155:e201129. [PMID: 32432699 DOI: 10.1001/jamasurg.2020.1129] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
139 Haimerl M, Verloh N, Fellner C, Zeman F, Teufel A, Fichtner-Feigl S, Schreyer AG, Stroszczynski C, Wiggermann P. MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep 2014;4:5621. [PMID: 25001391 DOI: 10.1038/srep05621] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
140 Ahluwalia V, Heuman DM, Feldman G, Wade JB, Thacker LR, Gavis E, Gilles H, Unser A, White MB, Bajaj JS. Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis. J Hepatol. 2015;62:75-82. [PMID: 25111174 DOI: 10.1016/j.jhep.2014.07.033] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
141 Xun YH, Shi JP, Li CQ, Li D, Shi WZ, Pan QC, Guo JC, Zang GQ. Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure. Mol Med Rep 2014;9:1559-68. [PMID: 24573151 DOI: 10.3892/mmr.2014.1983] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
142 Ge J, Najafi N, Zhao W, Somsouk M, Fang M, Lai JC. A Methodology to Generate Longitudinally Updated Acute-On-Chronic Liver Failure Prognostication Scores From Electronic Health Record Data. Hepatol Commun 2021;5:1069-80. [PMID: 34141990 DOI: 10.1002/hep4.1690] [Reference Citation Analysis]
143 Levy JJ, Azizgolshani N, Andersen MJ Jr, Suriawinata A, Liu X, Lisovsky M, Ren B, Bobak CA, Christensen BC, Vaickus LJ. A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies. Mod Pathol 2021;34:808-22. [PMID: 33299110 DOI: 10.1038/s41379-020-00718-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
144 Shrestha DB, Budhathoki P, Sedhai YR, Baniya R, Awal S, Yadav J, Awal L, Davis B, Kashiouris MG, Cable CA. Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis. Ann Hepatol 2021;:100547. [PMID: 34626828 DOI: 10.1016/j.aohep.2021.100547] [Reference Citation Analysis]
145 Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008;300:2371-2378. [PMID: 19033587 DOI: 10.1001/jama.2008.720] [Cited by in Crossref: 193] [Cited by in F6Publishing: 179] [Article Influence: 13.8] [Reference Citation Analysis]
146 Caraceni P, Angeli P, Prati D, Bernardi M, Liumbruno GM, Bennardello F, Piccoli P, Velati C; Italian Association for the Study of the Liver (AISF)., Italian Society of Transfusion Medicine and Immunohaematology (SIMTI). AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis. Blood Transfus 2016;14:8-22. [PMID: 26820615 DOI: 10.2450/2016.0294-15] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
147 Luo X, Leanza J, Massie AB, Garonzik-Wang JM, Haugen CE, Gentry SE, Ottmann SE, Segev DL. MELD as a metric for survival benefit of liver transplantation. Am J Transplant 2018;18:1231-7. [PMID: 29316310 DOI: 10.1111/ajt.14660] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
148 Koay EJ, Owen D, Das P. Radiation-Induced Liver Disease and Modern Radiotherapy. Semin Radiat Oncol 2018;28:321-31. [PMID: 30309642 DOI: 10.1016/j.semradonc.2018.06.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
149 Blok JJ, Putter H, Metselaar HJ, Porte RJ, Gonella F, de Jonge J, van den Berg AP, van der Zande J, de Boer JD, van Hoek B, Braat AE. Identification and Validation of the Predictive Capacity of Risk Factors and Models in Liver Transplantation Over Time. Transplant Direct 2018;4:e382. [PMID: 30234151 DOI: 10.1097/TXD.0000000000000822] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
150 Tong JJ, Zhao W, Mu XY, Xu X, Su HB, Liu XY, Chen J, Zhai XR, Wang Y, Hu JH. Predictive value of the Chinese group on the study of severe hepatitis B-acute-on-chronic liver failure score in the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Chin Med J (Engl) 2019;132:1541-9. [PMID: 31188162 DOI: 10.1097/CM9.0000000000000298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Bucsics T, Schoder M, Diermayr M, Feldner-Busztin M, Goeschl N, Bauer D, Schwabl P, Mandorfer M, Angermayr B, Cejna M, Ferlitsch A, Sieghart W, Trauner M, Peck-Radosavljevic M, Karner J, Karnel F, Reiberger T. Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience. PLoS One 2018;13:e0189414. [PMID: 29315304 DOI: 10.1371/journal.pone.0189414] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
152 Abbasi M, Kiani M, Ahmadi M, Salehi B. Knowledge and Ethical Issues in Organ Transplantation and Organ Donation: Perspectives from Iranian Health Personnel. Ann Transplant 2018;23:292-9. [PMID: 29724990 DOI: 10.12659/AOT.908615] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
153 Cholongitas E, Germani G, Burroughs AK. Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol. 2010;7:659-668. [PMID: 21045793 DOI: 10.1038/nrgastro.2010.169] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
154 Garrido M, Pereira Guedes T, Alves Silva J, Falcão D, Novo I, Archer S, Rocha M, Maia L, Sarmento-Castro R, Pedroto I. Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19. GE Port J Gastroenterol 2021;158:1-12. [PMID: 34192127 DOI: 10.1159/000513593] [Reference Citation Analysis]
155 Moon AM, Green PK, Rockey DC, Berry K, Ioannou GN. Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding. Aliment Pharmacol Ther 2020;51:364-73. [PMID: 31773763 DOI: 10.1111/apt.15586] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
156 Tseng MH, Cheng CJ, Sung CC, Chou YC, Chu P, Chen GS, Lin SH. Hyponatremia is a surrogate marker of poor outcome in peritoneal dialysis-related peritonitis. BMC Nephrol 2014;15:113. [PMID: 25012614 DOI: 10.1186/1471-2369-15-113] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
157 Lee HA, Jung JY, Lee YS, Jung YK, Kim JH, An H, Yim HJ, Jeen YT, Yeon JE, Byun KS, Um SH, Seo YS. Direct Bilirubin Is More Valuable than Total Bilirubin for Predicting Prognosis in Patients with Liver Cirrhosis. Gut Liver 2021;15:599-605. [PMID: 33293481 DOI: 10.5009/gnl20171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
158 Kim MS, Kato TS, Farr M, Wu C, Givens RC, Collado E, Mancini DM, Schulze PC. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction. J Am Coll Cardiol 2013;61:2253-61. [PMID: 23563127 DOI: 10.1016/j.jacc.2012.12.056] [Cited by in Crossref: 108] [Cited by in F6Publishing: 86] [Article Influence: 12.0] [Reference Citation Analysis]
159 Oikonomou T, Orfanidou A, Goulis I, Ntogramatzi F, Athanasiadou Z, Papatheodoridis GV, Cholongitas E. New prognostic score based on galectin-3 has similar performance to model for end-stage liver disease and sodium score in patients with stable decompensated cirrhosis. Ann Gastroenterol 2021;34:728-35. [PMID: 34475745 DOI: 10.20524/aog.2021.0633] [Reference Citation Analysis]
160 Patel S, Nguyen DS, Rastogi A, Nguyen MK, Nguyen MK. Treatment of Cirrhosis-Associated Hyponatremia with Midodrine and Octreotide. Front Med (Lausanne). 2017;4:17. [PMID: 28352627 DOI: 10.3389/fmed.2017.00017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
161 Goudsmit BFJ, Putter H, Tushuizen ME, de Boer J, Vogelaar S, Alwayn IPJ, van Hoek B, Braat AE. Invited response to "MELD calibration". Am J Transplant 2021;21:440-1. [PMID: 32893951 DOI: 10.1111/ajt.16289] [Reference Citation Analysis]
162 Pájer P, Fehérvári I. [Investigation of renal function in liver transplant patients: MDRD or Cockroft-Gault?]. Orv Hetil 2009;150:155-60. [PMID: 19144599 DOI: 10.1556/OH.2009.28543] [Reference Citation Analysis]
163 Cullaro G, Verna EC, Lee BP, Lai JC. Chronic Kidney Disease in Liver Transplant Candidates: A Rising Burden Impacting Post-Liver Transplant Outcomes. Liver Transpl. 2020;26:498-506. [PMID: 31785069 DOI: 10.1002/lt.25694] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
164 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications. Clin Mol Hepatol 2018;24:230-77. [PMID: 29991196 DOI: 10.3350/cmh.2018.1005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
165 Ma T, Li QS, Wang Y, Wang B, Wu Z, Lv Y, Wu RQ. Value of pretransplant albumin-bilirubin score in predicting outcomes after liver transplantation. World J Gastroenterol 2019; 25(15): 1879-1889 [PMID: 31057301 DOI: 10.3748/wjg.v25.i15.1879] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
166 Dziodzio T, Öllinger R, Schöning W, Rothkäppel A, Nikolov R, Juraszek A, Ritschl PV, Stockmann M, Pratschke J, Jara M. Validation of a new prognostic model to predict short and medium-term survival in patients with liver cirrhosis. BMC Gastroenterol 2020;20:265. [PMID: 32787947 DOI: 10.1186/s12876-020-01407-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
167 Somsouk M, Guy J, Biggins SW, Vittinghoff E, Kohn MA, Inadomi JM. Ascites improves upon [corrected] serum sodium plus [corrected] model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease. Aliment Pharmacol Ther. 2009;30:741-748. [PMID: 19604177 DOI: 10.1111/j.1365-2036.2009.04096.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
168 Goudsmit BFJ, Putter H, Tushuizen ME, de Boer J, Vogelaar S, Alwayn IPJ, van Hoek B, Braat AE. Validation of the Model for End-stage Liver Disease sodium (MELD-Na) score in the Eurotransplant region. Am J Transplant 2021;21:229-40. [PMID: 32529758 DOI: 10.1111/ajt.16142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
169 Xu J, Chen X, Wang X, Zhu C, Hu Y, Yang X, Xu C, Shen X. Preoperative Hyponatremia And Hypocalcemia Predict Poor Prognosis In Elderly Gastric Cancer Patients. Cancer Manag Res 2019;11:8765-80. [PMID: 31632136 DOI: 10.2147/CMAR.S211603] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
170 Györi GP, Pereyra D, Rumpf B, Hackl H, Köditz C, Ortmayr G, Reiberger T, Trauner M, Berlakovich GA, Starlinger P. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation. Hepatology 2020;72:584-94. [PMID: 31773739 DOI: 10.1002/hep.31047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
171 Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62:584-590. [PMID: 25846824 DOI: 10.1002/hep.27830] [Cited by in Crossref: 104] [Cited by in F6Publishing: 95] [Article Influence: 14.9] [Reference Citation Analysis]
172 Li H, Chen LY, Zhang NN, Li ST, Zeng B, Pavesi M, Amorós À, Mookerjee RP, Xia Q, Xue F, Ma X, Hua J, Sheng L, Qiu DK, Xie Q, Foster GR, Dusheiko G, Moreau R, Gines P, Arroyo V, Jalan R. Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B. Sci Rep. 2016;6:25487. [PMID: 27146801 DOI: 10.1038/srep25487] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 12.7] [Reference Citation Analysis]
173 Gaglio P, Marfo K, Chiodo J. Hyponatremia in cirrhosis and end-stage liver disease: treatment with the vasopressin V2-receptor antagonist tolvaptan. Dig Dis Sci. 2012;57:2774-2785. [PMID: 22732834 DOI: 10.1007/s10620-012-2276-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
174 Liu Z, Jia J, Ning H, Que S, Zhou L, Zheng S. Systematic Evaluation of the Safety Threshold for Allograft Macrovesicular Steatosis in Cadaveric Liver Transplantation. Front Physiol 2019;10:429. [PMID: 31105577 DOI: 10.3389/fphys.2019.00429] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
175 Yan L, Xie F, Lu J, Ni Q, Shi C, Tang C, Yang J. The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials. BMC Gastroenterol. 2015;15:65. [PMID: 26054761 DOI: 10.1186/s12876-015-0297-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
176 Nishikawa H, Enomoto H, Ishii A, Iwata Y, Miyamoto Y, Ishii N, Yuri Y, Hasegawa K, Nakano C, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Takata R, Iijima H, Nishiguchi S. Comparison of Prognostic Impact between the Child-Pugh Score and Skeletal Muscle Mass for Patients with Liver Cirrhosis. Nutrients 2017;9:E595. [PMID: 28604642 DOI: 10.3390/nu9060595] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
177 Kim G, Kang SH, Kim MY, Baik SK. Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis. PLoS One. 2017;12:e0186990. [PMID: 29065187 DOI: 10.1371/journal.pone.0186990] [Cited by in Crossref: 97] [Cited by in F6Publishing: 105] [Article Influence: 19.4] [Reference Citation Analysis]
178 Hayashi M, Abe K, Fujita M, Okai K, Takahashi A, Ohira H. Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia. Intern Med 2018;57:2451-8. [PMID: 29607963 DOI: 10.2169/internalmedicine.0629-17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
179 Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology. 2011;140:1952-1960. [PMID: 21334338 DOI: 10.1053/j.gastro.2011.02.017] [Cited by in Crossref: 94] [Cited by in F6Publishing: 77] [Article Influence: 8.5] [Reference Citation Analysis]
180 Nguyen K, Jimenez M, Moghadam N, Wu C, Farid A, Grotts J, Elashoff D, Choi G, Durazo FA, El-Kabany MM. Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals. J Clin Transl Hepatol. 2017;5:43-49. [PMID: 28507926 DOI: 10.14218/jcth.2016.00057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
181 Kaplan DE, Mehta R, D'Addeo K, Gade TP, Taddei TH. Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching. J Vasc Interv Radiol. 2018;29:540-549.e4. [PMID: 29477619 DOI: 10.1016/j.jvir.2017.11.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
182 Hawkins RB, Young BAC, Mehaffey JH, Speir AM, Quader MA, Rich JB, Ailawadi G; Investigators for the Virginia Cardiac Services Quality Initiative. Model for End-Stage Liver Disease Score Independently Predicts Mortality in Cardiac Surgery. Ann Thorac Surg 2019;107:1713-9. [PMID: 30639362 DOI: 10.1016/j.athoracsur.2018.12.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
183 Chen SH, Wan QS, Wang T, Zhang KH. Fluid Biomarkers for Predicting the Prognosis of Liver Cirrhosis. Biomed Res Int 2020;2020:7170457. [PMID: 32280697 DOI: 10.1155/2020/7170457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Lai JC, Rahimi RS, Verna EC, Kappus MR, Dunn MA, McAdams-DeMarco M, Haugen CE, Volk ML, Duarte-Rojo A, Ganger DR, O'Leary JG, Dodge JL, Ladner D, Segev DL. Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. Gastroenterology 2019;156:1675-82. [PMID: 30668935 DOI: 10.1053/j.gastro.2019.01.028] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 22.3] [Reference Citation Analysis]
185 Morales-Arráez D, Ventura-Cots M, Altamirano J, Abraldes JG, Cruz-Lemini M, Thursz MR, Atkinson SR, Sarin SK, Kim W, Chavez-Araujo R, Higuera-de la Tijera MF, Singal AK, Shah VH, Kamath PS, Duarte-Rojo A, Charles EA, Vargas V, Jager M, Rautou PE, Rincon D, Zamarripa F, Restrepo-Gutiérrez JC, Torre A, Lucey MR, Arab JP, Mathurin P, Louvet A, García-Tsao G, González JA, Verna EC, Brown RS Jr, Argemi J, Fernández-Carillo C, Clemente A, Alvarado-Tapias E, Forrest E, Allison M, Bataller R. The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study. Am J Gastroenterol 2021. [PMID: 34962498 DOI: 10.14309/ajg.0000000000001596] [Reference Citation Analysis]
186 Barbosa BC, Santos LAR, Daher GHRM, Martins DL, Perales SR, Gallani SK, Costa LBED, Lago EAD, Boin IFSF, Caserta NMG, Ataíde EC. Clinical impact of the Model for End Liver Disease (MELD) score on the presence of microvascular invasion and on the postoperative outcome in patients undergoing liver transplantation. Rev Col Bras Cir 2021;48:e20212997. [PMID: 34932735 DOI: 10.1590/0100-6991e-20212997] [Reference Citation Analysis]
187 Prié D, Forand A, Francoz C, Elie C, Cohen I, Courbebaisse M, Eladari D, Lebrec D, Durand F, Friedlander G. Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list. PLoS One 2013;8:e66182. [PMID: 23825530 DOI: 10.1371/journal.pone.0066182] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
188 Vaa BE, Asrani SK, Dunn W, Kamath PS, Shah VH. Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis. Mayo Clin Proc. 2011;86:37-42. [PMID: 21193654 DOI: 10.4065/mcp.2010.0281] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
189 Gong N, Jia C, Huang H, Liu J, Huang X, Wan Q. Predictors of Mortality During Initial Liver Transplant Hospitalization and Investigation of Causes of Death. Ann Transplant 2020;25:e926020. [PMID: 33273447 DOI: 10.12659/AOT.926020] [Reference Citation Analysis]
190 Liotta EM, Karvellas CJ, Kim M, Batra A, Naidech A, Prabhakaran S, Sorond FA, Kimberly WT, Maas MB. Serum osmolality, cerebrospinal fluid specific gravity and overt hepatic encephalopathy severity in patients with liver failure. Liver Int 2020;40:1977-86. [PMID: 32020734 DOI: 10.1111/liv.14400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
191 Goldberg DS, Olthoff KM. Standardizing MELD exceptions: Current challenges and future directions. Curr Transplant Rep. 2014;1:232-237. [PMID: 25530936 DOI: 10.1007/s40472-014-0027-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
192 Wedd JP, Harper AM, Biggins SW. MELD score, allocation, and distribution in the United States. Clin Liver Dis (Hoboken) 2013;2:148-51. [PMID: 30992850 DOI: 10.1002/cld.233] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
193 Kim TY, Suk KT, Jeong SW, Ryu T, Kim DJ, Baik SK, Sohn JH, Jeong WK, Choi E, Jang JY, Kim MY. The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients. J Korean Med Sci 2019;34:e223. [PMID: 31436052 DOI: 10.3346/jkms.2019.34.e223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Zhang GL, Zhang T, Zhao QY, Xie C, Lin CS, Gao ZL. Increased IL-17-producing CD8+ T cell frequency predicts short-term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure. Ther Clin Risk Manag. 2018;14:2127-2136. [PMID: 30464485 DOI: 10.2147/tcrm.s184809] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
195 Arain FA, Khaleghi M, Bailey KR, Lahr BD, Rooke TW, Kullo IJ. White blood cell count predicts all-cause mortality in patients with suspected peripheral arterial disease. Am J Med 2009;122:874.e1-7. [PMID: 19699384 DOI: 10.1016/j.amjmed.2009.02.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
196 Chen T, Yang Z, Choudhury AK, Al Mahtab M, Li J, Chen Y, Tan SS, Han T, Hu J, Hamid SS, Huei LG, Ghazinian H, Nan Y, Chawla YK, Yuen MF, Devarbhavi H, Shukla A, Abbas Z, Sahu M, Dokmeci AK, Lesmana LA, Lesmana CRA, Xin S, Duan Z, Guo W, Ma K, Zhang Z, Cheng Q, Jia J, Sharma BC, Sarin SK, Ning Q. Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region. Hepatol Int. 2019;13:695-705. [PMID: 31650510 DOI: 10.1007/s12072-019-09992-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
197 Zhai XR, Tong JJ, Wang HM, Xu X, Mu XY, Chen J, Liu ZF, Wang Y, Su HB, Hu JH. Infection deteriorating hepatitis B virus related acute-on-chronic liver failure: a retrospective cohort study. BMC Gastroenterol 2020;20:320. [PMID: 32993547 DOI: 10.1186/s12876-020-01473-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
198 Lee SW, Baek SH, Ahn SY, Na KY, Chae DW, Chin HJ, Kim S. The Effects of Pre-Existing Hyponatremia and Subsequent-Developing Acute Kidney Injury on In-Hospital Mortality: A Retrospective Cohort Study. PLoS One 2016;11:e0162990. [PMID: 27622451 DOI: 10.1371/journal.pone.0162990] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
199 Wang CH, Tsai CE, Cheng KW, Chen CL, Huang CJ, Wu SC, Shih TH, Yang SC, Juang SE, Liu CK, Jawan B, Hou SY. Anesthetic Fluid Management of Patients With Hyponatremia Undergoing Living Donor Liver Transplantation. Transplant Proc 2020;52:1798-801. [PMID: 32448660 DOI: 10.1016/j.transproceed.2020.01.144] [Reference Citation Analysis]
200 Polyak A, Kuo A, Sundaram V. Evolution of liver transplant organ allocation policy: Current limitations and future directions. World J Hepatol 2021; 13(8): 830-839 [PMID: 34552690 DOI: 10.4254/wjh.v13.i8.830] [Reference Citation Analysis]
201 Sakai T, Zerillo J. Noteworthy Literature Published in 2016 for Abdominal Organ Transplantation Anesthesiologists. Semin Cardiothorac Vasc Anesth 2017;21:58-69. [PMID: 28100111 DOI: 10.1177/1089253216688536] [Reference Citation Analysis]
202 Ferri F, Milana M, Abbatecola A, Pintore A, Lenci I, Parisse S, Vitale A, Di Croce G, Mennini G, Lai Q, Rossi M, Angelico R, Tisone G, Anselmo A, Angelico M, Corradini SG. Electronic Outpatient Referral System for Liver Transplant Improves Appropriateness and Allows First Visit Triage. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01091-0. [PMID: 34648952 DOI: 10.1016/j.cgh.2021.10.005] [Reference Citation Analysis]
203 Bartoletti M, Baldassarre M, Domenicali M, Lewis RE, Giannella M, Antognoli A, Rinaldi M, Zaccherini G, Verucchi G, Marconi L, Tamè M, Berardi S, Napoli L, Siniscalchi A, Fabbri A, Biselli M, Tufoni M, Pavarin RM, Trevisani F, Viale P, Bernardi M, Caraceni P. Prognostic Role of Bacterial and Fungal Infections in Patients With Liver Cirrhosis With and Without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study. Open Forum Infect Dis 2020;7:ofaa453. [PMID: 33209950 DOI: 10.1093/ofid/ofaa453] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
204 Cywinski JB, Mascha EJ, You J, Sessler DI, Kapural L, Argalious M, Parker BM. Pre-transplant MELD and sodium MELD scores are poor predictors of graft failure and mortality after liver transplantation. Hepatol Int 2011;5:841-9. [PMID: 21484127 DOI: 10.1007/s12072-011-9257-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
205 Biolato M, Miele L, Vero V, Racco S, Stasi CD, Iezzi R, Zanché A, Pompili M, Rapaccini GL, Torre GL, Gasbarrini A, Grieco A. Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: Serum sodium predicts survival. World J Gastroenterol 2014; 20(25): 8158-8165 [PMID: 25009388 DOI: 10.3748/wjg.v20.i25.8158] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
206 Jeppesen AN, Jensen HK, Donskov F, Marcussen N, von der Maase H. Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma. Br J Cancer 2010;102:867-72. [PMID: 20145619 DOI: 10.1038/sj.bjc.6605563] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 5.5] [Reference Citation Analysis]
207 Saldaña RS, Schrem H, Barthold M, Kaltenborn A. Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients. PLoS One 2017;12:e0170499. [PMID: 28129338 DOI: 10.1371/journal.pone.0170499] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
208 Xu L, Ye H, Huang F, Yang Z, Zhu B, Xu Y, Qiu Y, Li L. Moderate/Severe hyponatremia increases the risk of death among hospitalized Chinese human immunodeficiency virus/acquired immunodeficiency syndrome patients. PLoS One 2014;9:e111077. [PMID: 25360785 DOI: 10.1371/journal.pone.0111077] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
209 Ling Q, Dai H, Zhuang R, Shen T, Wang W, Xu X, Zheng S. Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry. Sci Rep 2017;7:42253. [PMID: 28198820 DOI: 10.1038/srep42253] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
210 Kniese C, Diab K, Ghabril M, Bosslet G. Indwelling Pleural Catheters in Hepatic Hydrothorax: A Single-Center Series of Outcomes and Complications. Chest 2019;155:307-14. [PMID: 29990479 DOI: 10.1016/j.chest.2018.07.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
211 Lindsay A. Profound hyponatremia in cirrhosis: a case report. Cases J 2010;3:77. [PMID: 20331881 DOI: 10.1186/1757-1626-3-77] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
212 Qiao L, Tan W, Wang X, Zheng X, Huang Y, Li B, Meng Z, Gao Y, Qian Z, Liu F, Lu X, Shang J, Liu J, Yan H, Gu W, Zhang Y, Xiang X, Hou Y, Zhang Q, Xiong Y, Zou C, Chen J, Huang Z, Jiang X, Luo S, Chen Y, Gao N, Liu C, Yuan W, Mei X, Li J, Li T, Zheng R, Zhou X, Chen J, Deng G, Zhang W, Li H. Different Effects of Total Bilirubin on 90-Day Mortality in Hospitalized Patients With Cirrhosis and Advanced Fibrosis: A Quantitative Analysis. Front Med (Lausanne) 2021;8:704452. [PMID: 34249983 DOI: 10.3389/fmed.2021.704452] [Reference Citation Analysis]
213 Rachakonda V, Argemi J, Borhani AA, Bataller R, Tevar A, Behari J. Reduced Serum Sphingolipids Constitute a Molecular Signature of Malnutrition in Hospitalized Patients With Decompensated Cirrhosis. Clin Transl Gastroenterol 2019;10:e00013. [PMID: 30908309 DOI: 10.14309/ctg.0000000000000013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
214 Bahra M, Neuhaus P. Liver transplantation in the high MELD era: a fair chance for everyone? Langenbecks Arch Surg. 2011;396:461-465. [PMID: 21384189 DOI: 10.1007/s00423-011-0766-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
215 Forde KA, Fallon MB, Krowka MJ, Sprys M, Goldberg DS, Krok KL, Patel M, Lin G, Oh JK, Mottram CD, Scanlon PD, Kawut SM; Pulmonary Vascular Complications of Liver Disease 2 Study Group. Pulse Oximetry Is Insensitive for Detection of Hepatopulmonary Syndrome in Patients Evaluated for Liver Transplantation. Hepatology 2019;69:270-81. [PMID: 30070715 DOI: 10.1002/hep.30139] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
216 Bernardi M, Ricci CS, Santi L. Hyponatremia in Patients with Cirrhosis of the Liver. J Clin Med. 2014;4:85-101. [PMID: 26237020 DOI: 10.3390/jcm4010085] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
217 Jepsen P, Ott P, Andersen PK, Vilstrup H. The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia--a historical cohort study. BMC Res Notes 2012;5:509. [PMID: 22988833 DOI: 10.1186/1756-0500-5-509] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
218 Ivanics T, Leonard-Murali S, Mouzaihem H, Moonka D, Kitajima T, Yeddula S, Shamaa MT, Rizzari M, Collins K, Yoshida A, Abouljoud M, Nagai S. Extreme hyponatremia as a risk factor for early mortality after liver transplantation in the MELD-sodium era. Transpl Int 2021. [PMID: 34580929 DOI: 10.1111/tri.14123] [Reference Citation Analysis]
219 Hoyer DP, Minor T. Graft Reconditioning before Liver Transplantation. Visc Med 2016;32:250-6. [PMID: 27722161 DOI: 10.1159/000446378] [Reference Citation Analysis]
220 Nishikawa H, Osaki Y. Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis. Mediators Inflamm. 2015;2015:872152. [PMID: 26494949 DOI: 10.1155/2015/872152] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
221 Dogan S, Gurakar A. Liver Transplantation Update: 2014. Euroasian J Hepatogastroenterol 2015;5:98-106. [PMID: 29201702 DOI: 10.5005/jp-journals-10018-1144] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
222 Lindenmeyer CC, Flocco G, Sanghi V, Lopez R, Kim AJ, Niyazi F, Mehta NA, Kapoor A, Carey WD, Mireles-Cabodevila E, Romero-Marrero C. LIV-4: A novel model for predicting transplant-free survival in critically ill cirrhotics. World J Hepatol 2020; 12(6): 298-311 [PMID: 32742572 DOI: 10.4254/wjh.v12.i6.298] [Reference Citation Analysis]
223 Deitelzweig SB, McCormick L. Hyponatremia in hospitalized patients: the potential role of tolvaptan. Hosp Pract (1995) 2011;39:87-98. [PMID: 21881396 DOI: 10.3810/hp.2011.08.584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
224 Jara M, Dziodzio T, Malinowski M, Lüttgert K, Nikolov R, Ritschl PV, Öllinger R, Pratschke J, Stockmann M. Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis. Dig Dis Sci 2019;64:576-84. [PMID: 30406480 DOI: 10.1007/s10620-018-5360-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
225 Xu X, Tan J, Wang H, Zhao W, Qin B. Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days. Front Med (Lausanne) 2021;8:646875. [PMID: 34136498 DOI: 10.3389/fmed.2021.646875] [Reference Citation Analysis]
226 Lawson EA, Fazeli PK, Calder G, Putnam H, Misra M, Meenaghan E, Miller KK, Klibanski A. Plasma sodium level is associated with bone loss severity in women with anorexia nervosa: a cross-sectional study. J Clin Psychiatry 2012;73:e1379-83. [PMID: 23218167 DOI: 10.4088/JCP.12m07919] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
227 Kasztelan-Szczerbinska B, Slomka M, Celinski K, Szczerbinski M. Alkaline phosphatase: the next independent predictor of the poor 90-day outcome in alcoholic hepatitis. Biomed Res Int. 2013;2013:614081. [PMID: 24151614 DOI: 10.1155/2013/614081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
228 Qin G, Bian ZL, Shen Y, Zhang L, Zhu XH, Liu YM, Shao JG. Logistic regression model can reduce unnecessary artificial liver support in hepatitis B virus-associated acute-on-chronic liver failure: decision curve analysis. BMC Med Inform Decis Mak 2016;16:59. [PMID: 27260306 DOI: 10.1186/s12911-016-0302-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
229 Xu Y, Li N, Lu M, Dixon E, Myers RP, Jolley RJ, Quan H. Comparison of risk adjustment methods in patients with liver disease using electronic medical record data. BMC Gastroenterol 2017;17:5. [PMID: 28061757 DOI: 10.1186/s12876-016-0559-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
230 Winther JA, Brynildsen J, Høiseth AD, Følling I, Brekke PH, Christensen G, Hagve TA, Verbalis JG, Omland T, Røsjø H. Prevalence and Prognostic Significance of Hyponatremia in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Data from the Akershus Cardiac Examination (ACE) 2 Study. PLoS One 2016;11:e0161232. [PMID: 27529844 DOI: 10.1371/journal.pone.0161232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
231 Kohli R, Shingina A, New S, Chaturvedi S, Benson A, Biggins SW, Bambha K. Thromboelastography Parameters Are Associated with Cirrhosis Severity. Dig Dis Sci 2019;64:2661-70. [PMID: 30915655 DOI: 10.1007/s10620-019-05597-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
232 Jundt MC, Owen RL, Thompson SM, Fleming CJ, Stockland AH, Andrews JC. MELD-Na > 16 is associated with high peri-procedural and short-term mortality in patients with ruptured hepatocellular carcinoma treated with emergent transarterial embolization. Abdom Radiol (NY) 2021. [PMID: 34633495 DOI: 10.1007/s00261-021-03306-2] [Reference Citation Analysis]
233 Michel M, Hess C, Kaps L, Kremer WM, Hilscher M, Galle PR, Moehler M, Schattenberg JM, Wörns MA, Labenz C, Nagel M. Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis. Sci Rep 2021;11:20506. [PMID: 34654829 DOI: 10.1038/s41598-021-00119-7] [Reference Citation Analysis]
234 Nadim MK, DiNorcia J, Ji L, Groshen S, Levitsky J, Sung RS, Kim WR, Andreoni K, Mulligan D, Genyk YS. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease. J Hepatol 2017;67:517-25. [PMID: 28483678 DOI: 10.1016/j.jhep.2017.04.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
235 Mihaylov P, Nagai S, Ekser B, Mangus R, Fridell J, Kubal C. Prognostic Impact of Peritransplant Serum Sodium Concentrations in Liver Transplantation. Ann Transplant. 2019;24:418-425. [PMID: 31308357 DOI: 10.12659/aot.914951] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
236 Kim HY, Jang JW. Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score. World J Gastroenterol 2015; 21(25): 7637-7647 [PMID: 26167066 DOI: 10.3748/wjg.v21.i25.7637] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 48] [Article Influence: 8.1] [Reference Citation Analysis]
237 Zhang Q, Li Y, Han T, Nie C, Cai J, Liu H, Liu Y. Comparison of current diagnostic criteria for acute-on-chronic liver failure. PLoS One 2015;10:e0122158. [PMID: 25785855 DOI: 10.1371/journal.pone.0122158] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
238 Namba M, Hiramatsu A, Aikata H, Kodama K, Uchikawa S, Ohya K, Morio K, Fujino H, Nakahara T, Murakami E, Yamauchi M, Kawaoka T, Tsuge M, Imamura M, Chayama K. Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis. J Gastroenterol 2020;55:217-26. [PMID: 31485782 DOI: 10.1007/s00535-019-01623-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
239 Chen XB, Zhu X, Tang H. Value of KCH criteria, MELD score and MELDNa score for prediction of prognosis of acute liver failure. Shijie Huaren Xiaohua Zazhi 2011; 19(8): 855-859 [DOI: 10.11569/wcjd.v19.i8.855] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
240 El-Ghannam MT, Hassanien MH, El-Talkawy MD, Saleem AAA, Sabry AI, Abu Taleb HM. Performance of Disease-Specific Scoring Models in Intensive Care Patients with Severe Liver Diseases. J Clin Diagn Res 2017;11:OC12-6. [PMID: 28764217 DOI: 10.7860/JCDR/2017/24543.9980] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
241 Kitajima T, Moonka D, Yeddula S, Rizzari M, Collins K, Yoshida A, Abouljoud MS, Nagai S. Liver transplant waitlist outcomes in alcoholic hepatitis compared with other liver diseases: An analysis of UNOS registry. Clin Transplant 2020;34:e13837. [PMID: 32073688 DOI: 10.1111/ctr.13837] [Reference Citation Analysis]
242 Luo Y, Xu Y, Li M, Xie Y, Gong G. A new multiparameter integrated MELD model for prognosis of HBV-related acute-on-chronic liver failure. Medicine (Baltimore) 2016;95:e4696. [PMID: 27559979 DOI: 10.1097/MD.0000000000004696] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
243 Nishikawa H, Yuri Y, Enomoto H, Ishii A, Iwata Y, Miyamoto Y, Ishii N, Hasegawa K, Nakano C, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Takata R, Iijima H, Nishiguchi S. Effect of psoas muscle mass after endoscopic therapy for patients with esophageal varices. Medicine (Baltimore) 2017;96:e6868. [PMID: 28489785 DOI: 10.1097/MD.0000000000006868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
244 Zhang GL, Zhao QY, Xie C, Peng L, Zhang T, Gao ZL. Elevated Serum IgG Levels Positively Correlated with IL-27 May Indicate Poor Outcome in Patients with HBV-Related Acute-On-Chronic Liver Failure. J Immunol Res 2019;2019:1538439. [PMID: 31198792 DOI: 10.1155/2019/1538439] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
245 Habib S, Boyer TD. Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia. Therap Adv Gastroenterol 2012;5:189-97. [PMID: 22570679 DOI: 10.1177/1756283X12437357] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
246 Saxena V, Lai JC. Kidney Failure and Liver Allocation: Current Practices and Potential Improvements. Adv Chronic Kidney Dis. 2015;22:391-398. [PMID: 26311601 DOI: 10.1053/j.ackd.2015.05.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
247 Goudsmit BFJ, Braat AE, Tushuizen ME, Coenraad MJ, Vogelaar S, Alwayn IPJ, van Hoek B, Putter H. Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure. JHEP Rep 2021;3:100369. [PMID: 34765960 DOI: 10.1016/j.jhepr.2021.100369] [Reference Citation Analysis]
248 Bolondi G, Mocchegiani F, Montalti R, Nicolini D, Vivarelli M, De Pietri L. Predictive factors of short term outcome after liver transplantation: A review. World J Gastroenterol 2016; 22(26): 5936-5949 [PMID: 27468188 DOI: 10.3748/wjg.v22.i26.5936] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
249 Viveiros A, Finkenstedt A, Schaefer B, Mandorfer M, Scheiner B, Lehner K, Tobiasch M, Reiberger T, Tilg H, Edlinger M, Zoller H. Transferrin as a predictor of survival in cirrhosis. Liver Transpl. 2018;24:343-351. [PMID: 29149510 DOI: 10.1002/lt.24981] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
250 Hagan MT, Sayuk GS, Lisker-Melman M, Korenblat KM, Kerr TA, Chapman WC, Crippin JS. Liver volume in the cirrhotic patient: does size matter? Dig Dis Sci 2014;59:886-91. [PMID: 24504591 DOI: 10.1007/s10620-014-3038-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
251 Nishikawa H, Kita R, Kimura T, Ohara Y, Sakamoto A, Saito S, Nishijima N, Nasu A, Komekado H, Osaki Y. Hyponatremia in hepatocellular carcinoma complicating with cirrhosis. J Cancer 2015;6:482-9. [PMID: 25874013 DOI: 10.7150/jca.11665] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
252 Manka P, Bechmann LP, Tacke F, Sowa JP, Schlattjan M, Kälsch J, Jochum C, Paul A, Saner FH, Trautwein C, Gerken G, Canbay A. Serum sodium based modification of the MELD does not improve prediction of outcome in acute liver failure. BMC Gastroenterol 2013;13:58. [PMID: 23551795 DOI: 10.1186/1471-230X-13-58] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
253 Cullaro G, Verna EC, Duarte-Rojo A, Kappus MR, Ganger DR, Rahimi RS, Boyarsky B, Segev DL, McAdams-DeMarco M, Ladner DP, Volk ML, Hsu CY, Lai JC. Frailty and the Risk of Acute Kidney Injury Among Patients With Cirrhosis. Hepatol Commun 2021. [PMID: 34676697 DOI: 10.1002/hep4.1840] [Reference Citation Analysis]
254 Moini M, Yazdani Sarvestani M, Shams M, Nomovi M. Evaluation of Adrenal Function in Nonhospitalized Patients with Cirrhosis. Can J Gastroenterol Hepatol. 2017;2017:2354253. [PMID: 28812008 DOI: 10.1155/2017/2354253] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
255 Egbe AC, Miranda WR, Dearani J, Kamath PS, Connolly HM. Prognostic Role of Hepatorenal Function Indexes in Patients With Ebstein Anomaly. J Am Coll Cardiol 2020;76:2968-76. [PMID: 33334426 DOI: 10.1016/j.jacc.2020.10.035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
256 Acharya G, Kaushik RM, Gupta R, Kaushik R. Child-Turcotte-Pugh Score, MELD Score and MELD-Na Score as Predictors of Short-Term Mortality among Patients with End-Stage Liver Disease in Northern India. Inflamm Intest Dis 2020;5:1-10. [PMID: 32232049 DOI: 10.1159/000503921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
257 Fortune BE, Garcia-Tsao G. Hypervolemic hyponatremia: Clinical significance and management. Clin Liver Dis (Hoboken) 2013;2:109-12. [PMID: 30992838 DOI: 10.1002/cld.179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
258 Lee M, Kim W, Choi Y, Kim S, Kim D, Yu SJ, Lee JH, Kim HY, Jung YJ, Kim BG, Kim YJ, Yoon JH, Lee KL, Lee HS. Spontaneous evolution in bilirubin levels predicts liver-related mortality in patients with alcoholic hepatitis. PLoS One 2014;9:e100870. [PMID: 25013906 DOI: 10.1371/journal.pone.0100870] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
259 Dhir M, Smith LM, Ullrich F, Leiphrakpam PD, Ly QP, Sasson AR, Are C. Pre-operative Nomogram to Predict Risk of Peri-operative Mortality following Liver Resections for Malignancy. J Gastrointest Surg 2010;14:1770-81. [DOI: 10.1007/s11605-010-1352-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
260 Lin YJ, Chen RJ, Tang JH, Yu CS, Wu JL, Chen LC, Chang SS. Machine-Learning Monitoring System for Predicting Mortality Among Patients With Noncancer End-Stage Liver Disease: Retrospective Study. JMIR Med Inform 2020;8:e24305. [PMID: 33124991 DOI: 10.2196/24305] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
261 Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med. 2009;122:857-865. [PMID: 19699382 DOI: 10.1016/j.amjmed.2009.01.027] [Cited by in Crossref: 388] [Cited by in F6Publishing: 307] [Article Influence: 29.8] [Reference Citation Analysis]
262 Russo FP, Ferrarese A, Zanetto A. Recent advances in understanding and managing liver transplantation. F1000Res. 2016;5. [PMID: 28105300 DOI: 10.12688/f1000research.8768.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
263 Furukawa J, Miyake H, Kusuda Y, Fujisawa M. Hyponatremia as a powerful prognostic predictor for Japanese patients with clear cell renal cell carcinoma treated with a tyrosine kinase inhibitor. Int J Clin Oncol 2015;20:351-7. [PMID: 24894624 DOI: 10.1007/s10147-014-0713-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
264 Gaduputi V, Abdulsamad M, Sakam S, Abbas N, Tariq H, Ihimoyan A. Systemic vascular resistance in cirrhosis: a predictor of severity? Hepat Med 2014;6:95-101. [PMID: 25187743 DOI: 10.2147/HMER.S67036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
265 Chen W, You J, Chen J, Zheng Q, Jiang JJ, Zhu YY. Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2017; 23(40): 7303-7309 [PMID: 29142477 DOI: 10.3748/wjg.v23.i40.7303] [Reference Citation Analysis]
266 Estilo A, McCormick L, Rahman M. Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study. Adv Ther 2021;38:5721-36. [PMID: 34693505 DOI: 10.1007/s12325-021-01947-9] [Reference Citation Analysis]
267 Tawfik AK, Helmy A, Yousef M, Abou-Saif S, Kobtan A, Asaad E, Abd-Elsalam S. Copeptin as a novel marker predicting prognosis of liver cirrhosis and its major complications. Hepat Med 2018;10:87-93. [PMID: 30214326 DOI: 10.2147/HMER.S174267] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
268 Guha C, Kavanagh BD. Hepatic radiation toxicity: avoidance and amelioration. Semin Radiat Oncol. 2011;21:256-263. [PMID: 21939854 DOI: 10.1016/j.semradonc.2011.05.003] [Cited by in Crossref: 127] [Cited by in F6Publishing: 109] [Article Influence: 12.7] [Reference Citation Analysis]
269 Manka P, Canbay A, Bechmann LP. Model for end-stage liver disease-sodium in acute-on-chronic liver failure. J Hepatol 2020;73:1578-9. [PMID: 32933782 DOI: 10.1016/j.jhep.2020.07.022] [Reference Citation Analysis]
270 Costabeber AM, Granzotto M, de Medeiros Fleck A, Marroni CA, Zanotelli ML, Cantisani G, Lionço L, Musskopf MI, Brandão A. Liver retransplantation in adults: a 20–year experience of one center in southern Brazil. Annals of Hepatology 2013;12:942-51. [DOI: 10.1016/s1665-2681(19)31300-6] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
271 Weissenborn K. Minimal/Covert Hepatic Encephalopathy - Impact of Comorbid Conditions. J Clin Exp Hepatol 2019;9:109-11. [PMID: 30765943 DOI: 10.1016/j.jceh.2018.08.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
272 Shah SR, Bhave G. Using Electrolyte Free Water Balance to Rationalize and Treat Dysnatremias. Front Med (Lausanne) 2018;5:103. [PMID: 29740578 DOI: 10.3389/fmed.2018.00103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
273 Mindikoglu AL, Pappas SC. New Developments in Hepatorenal Syndrome. Clin Gastroenterol Hepatol 2018;16:162-177.e1. [PMID: 28602971 DOI: 10.1016/j.cgh.2017.05.041] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 5.2] [Reference Citation Analysis]
274 Tapper EB, Parikh ND, Green PK, Berry K, Waljee AK, Moon AM, Ioannou GN. Reduced Incidence of Hepatic Encephalopathy and Higher Odds of Resolution Associated With Eradication of HCV Infection. Clin Gastroenterol Hepatol 2020;18:1197-1206.e7. [PMID: 31589975 DOI: 10.1016/j.cgh.2019.09.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
275 Chen EQ, Zeng F, Zhou LY, Tang H. Early warning and clinical outcome prediction of acute-on-chronic hepatitis B liver failure. World J Gastroenterol 2015; 21(42): 11964-11973 [PMID: 26576085 DOI: 10.3748/wjg.v21.i42.11964] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
276 Kang SH, Jeong WK, Baik SK, Cha SH, Kim MY. Impact of sarcopenia on prognostic value of cirrhosis: Going beyond the hepatic venous pressure gradient and MELD score. J Cachexia Sarcopenia Muscle. 2018;9:860-870. [PMID: 30371017 DOI: 10.1002/jcsm.12333] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
277 Kim HJ, Lee HW. Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol. 2013;19:105-115. [PMID: 23837134 DOI: 10.3350/cmh.2013.19.2.105] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 6.8] [Reference Citation Analysis]
278 Mindikoglu AL, Opekun AR, Mitch WE, Magder LS, Christenson RH, Dowling TC, Weir MR, Seliger SL, Howell CD, Raufman JP, Rana A, Goss JA, Khaderi SA, Vierling JM. Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis. Dig Dis Sci 2018;63:665-75. [PMID: 29392554 DOI: 10.1007/s10620-017-4897-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
279 Hwang JC, Jiang MY, Wang CT. Lower serum potassium combined with lower sodium concentrations predict long-term mortality risk in hemodialysis patients. BMC Nephrol 2013;14:269. [PMID: 24305468 DOI: 10.1186/1471-2369-14-269] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
280 Lenci I, Milana M, Grassi G, Signorello A, Aglitti A, Baiocchi L. Natremia and liver transplantation: The right amount of salt for a good recipe. World J Hepatol 2020; 12(11): 919-930 [PMID: 33312419 DOI: 10.4254/wjh.v12.i11.919] [Reference Citation Analysis]
281 Sharma P, Schaubel DE, Goodrich NP, Merion RM. Serum sodium and survival benefit of liver transplantation. Liver Transpl. 2015;21:308-313. [PMID: 25504743 DOI: 10.1002/lt.24063] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
282 Myers RP, Shaheen AA, Faris P, Aspinall AI, Burak KW. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list. PLoS One 2013;8:e51926. [PMID: 23349678 DOI: 10.1371/journal.pone.0051926] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
283 Roberts JP. Transplantation: Allocation of liver transplants-a road to consensus. Nat Rev Gastroenterol Hepatol 2015;12:615-6. [PMID: 26503885 DOI: 10.1038/nrgastro.2015.181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
284 Smith JM, Biggins SW, Haselby DG, Kim WR, Wedd J, Lamb K, Thompson B, Segev DL, Gustafson S, Kandaswamy R, Stock PG, Matas AJ, Samana CJ, Sleeman EF, Stewart D, Harper A, Edwards E, Snyder JJ, Kasiske BL, Israni AK. Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant. 2012;12:3191-3212. [PMID: 23157207 DOI: 10.1111/j.1600-6143.2012.04259.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 63] [Article Influence: 8.3] [Reference Citation Analysis]
285 Bae E, Lee TW, Jang HN, Cho HS, Jung S, Lee S, Chang SH, Park DJ. Lower serum sodium levels predict poor clinical outcomes in patients with insomnia. BMC Nephrol 2020;21:386. [PMID: 32891121 DOI: 10.1186/s12882-020-02051-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
286 Olson JC. Intensive Care Management of Patients with Cirrhosis. Curr Treat Options Gastroenterol 2018;16:241-52. [PMID: 29616404 DOI: 10.1007/s11938-018-0182-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
287 Burak KW, Meeberg GA, Myers RP, Fick GH, Swain MG, Bain VG, Kneteman NM, Hilsden RJ. Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in Canada. Can J Gastroenterol Hepatol 2016;2016:1329532. [PMID: 27446823 DOI: 10.1155/2016/1329532] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
288 Kim HY, Kim CW, Kim TY, Song DS, Sinn DH, Yoon EL, Jung YK, Suk KT, Lee SS, Lee CH, Kim TH, Kim JH, Yim HJ, Kim SE, Baik SK, Lee BS, Jang JY, Kim YS, Kim SG, Yang JM, Sohn JH, Lee HJ, Park SH, Choi EH, Kim DJ, Korean Acute-on-Chronic Liver Failure Study Group. Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis. World J Gastroenterol 2016; 22(41): 9205-9213 [PMID: 27895407 DOI: 10.3748/wjg.v22.i41.9205] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
289 Yang XA, Lv F, Wang R, Chang Y, Zhao Y, Cui X, Li H, Yang S, Li S, Zhao X, Mo Z, Yang F. Potential role of intestinal microflora in disease progression among patients with different stages of Hepatitis B.Gut Pathog. 2020;12:50. [PMID: 33117435 DOI: 10.1186/s13099-020-00391-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
290 Zamberg I, Maillard J, Assouline B, Tomala S, Keli-Barcelos G, Aldenkortt F, Mavrakanas T, Andres A, Schiffer E. Perioperative Evolution of Sodium Levels in Cirrhotic Patients Undergoing Liver Transplantation: An Observational Cohort and Literature Review. Hepat Med 2021;13:71-82. [PMID: 34393524 DOI: 10.2147/HMER.S320127] [Reference Citation Analysis]
291 Cullaro G, Hirose R, Lai JC. Changes in Simultaneous Liver-kidney Transplant Allocation Policy May Impact Postliver Transplant Outcomes. Transplantation 2019;103:959-64. [PMID: 30086097 DOI: 10.1097/TP.0000000000002403] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
292 Moritz ML, Ayus JC. New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children. Pediatr Nephrol. 2010;25:1225-1238. [PMID: 19894066 DOI: 10.1007/s00467-009-1323-6] [Cited by in Crossref: 88] [Cited by in F6Publishing: 57] [Article Influence: 6.8] [Reference Citation Analysis]
293 Schilsky ML, Moini M. Advances in liver transplantation allocation systems. World J Gastroenterol 2016; 22(10): 2922-2930 [PMID: 26973389 DOI: 10.3748/wjg.v22.i10.2922] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
294 Henson JB, Simon TG, Kaplan A, Osganian S, Masia R, Corey KE. Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2020;51:728-36. [PMID: 32043602 DOI: 10.1111/apt.15660] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 16.0] [Reference Citation Analysis]
295 Farkas S, Hackl C, Schlitt HJ. Overview of the indications and contraindications for liver transplantation. Cold Spring Harb Perspect Med. 2014;4. [PMID: 24789874 DOI: 10.1101/cshperspect.a015602] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
296 Chung MY, Jun DW, Sung SA. Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis. Korean J Hepatol. 2010;16:301-307. [PMID: 20924213 DOI: 10.3350/kjhep.2010.16.3.301] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
297 Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol 2014; 20(25): 8061-8071 [PMID: 25009378 DOI: 10.3748/wjg.v20.i25.8061] [Cited by in CrossRef: 128] [Cited by in F6Publishing: 116] [Article Influence: 16.0] [Reference Citation Analysis]
298 Gross P. Clinical management of SIADH. Ther Adv Endocrinol Metab 2012;3:61-73. [PMID: 23148195 DOI: 10.1177/2042018812437561] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
299 Gianotti RJ, Cardenas A. Hyponatraemia and cirrhosis. Gastroenterol Rep (Oxf) 2014;2:21-6. [PMID: 24760233 DOI: 10.1093/gastro/got037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
300 Bittermann T, Makar G, Goldberg D. Exception point applications for 15 points: an unintended consequence of the share 15 policy. Liver Transpl 2012;18:1302-9. [PMID: 22899664 DOI: 10.1002/lt.23537] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
301 Jiang AA, Greenwald HS, Sheikh L, Wooten DA, Malhotra A, Schooley RT, Sweeney DA. Predictors of Acute Liver Failure in Patients With Acute Hepatitis A: An Analysis of the 2016-2018 San Diego County Hepatitis A Outbreak. Open Forum Infect Dis 2019;6:ofz467. [PMID: 31777757 DOI: 10.1093/ofid/ofz467] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
302 Takahashi N, Ochiai D, Yamada Y, Tamagawa M, Kanamori H, Kato M, Ikenoue S, Kasuga Y, Kuroda T, Tanaka M. Prepregnancy Assessment of Liver Function to Predict Perinatal and Postpregnancy Outcomes in Biliary Atresia Patients with Native Liver. J Clin Med 2021;10:3956. [PMID: 34501403 DOI: 10.3390/jcm10173956] [Reference Citation Analysis]
303 Vagefi PA, Bertsimas D, Hirose R, Trichakis N. The rise and fall of the model for end-stage liver disease score and the need for an optimized machine learning approach for liver allocation. Curr Opin Organ Transplant 2020;25:122-5. [PMID: 32073494 DOI: 10.1097/MOT.0000000000000734] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
304 Garg G, Dixit VK, Shukla SK, Singh SK, Sachan S, Tiwari A, Yadav VK, Yadav DP. Impact of Direct Acting Antiviral Drugs in Treatment Naïve HCV Cirrhosis on Fibrosis and Severity of Liver Disease: A Real Life Experience from a Tertiary Care Center of North India. J Clin Exp Hepatol 2018;8:241-9. [PMID: 30302040 DOI: 10.1016/j.jceh.2017.11.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
305 Shin J, Yu JH, Jin YJ, Yim HJ, Jung YK, Yang JM, Song DS, Kim YS, Kim SG, Kim DJ, Suk KT, Yoon EL, Lee SS, Kim CW, Kim HY, Jang JY, Jeong SW. Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding. Clin Mol Hepatol 2020;26:540-53. [PMID: 32937688 DOI: 10.3350/cmh.2020.0034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
306 Shen Y, Wang X, Zhang S, Qin G, Liu Y, Lu Y, Liang F, Zhuang X. A comprehensive validation of HBV-related acute-on-chronic liver failure models to assist decision-making in targeted therapeutics. Sci Rep 2016;6:33389. [PMID: 27633520 DOI: 10.1038/srep33389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
307 Leise MD, Yun BC, Larson JJ, Benson JT, Yang JD, Therneau TM, Rosen CB, Heimbach JK, Biggins SW, Kim WR. Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation. Liver Transpl. 2014;20:687-697. [PMID: 24616214 DOI: 10.1002/lt.23860] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
308 Wang CW, Covinsky KE, Feng S, Hayssen H, Segev DL, Lai JC. Functional impairment in older liver transplantation candidates: From the functional assessment in liver transplantation study. Liver Transpl 2015;21:1465-70. [PMID: 26359787 DOI: 10.1002/lt.24334] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
309 Cavaggioni G, Poli E, Ferri F, Parlati L, Monaco V, Melcore C, Lattanzi B, Merli M, Mennini G, Melandro F, Rossi M, Ginanni Corradini S. MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective. Metab Brain Dis 2017;32:923-33. [DOI: 10.1007/s11011-017-9987-2] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
310 Quante M, Benckert C, Thelen A, Jonas S. Experience Since MELD Implementation: How Does the New System Deliver? Int J Hepatol. 2012;2012:264015. [PMID: 23091734 DOI: 10.1155/2012/264015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
311 Guo A, Mazumder NR, Ladner DP, Foraker RE. Predicting mortality among patients with liver cirrhosis in electronic health records with machine learning. PLoS One 2021;16:e0256428. [PMID: 34464403 DOI: 10.1371/journal.pone.0256428] [Reference Citation Analysis]
312 Prohic D, Mesihovic R, Vanis N, Puhalovic A. Prognostic Significance of Ascites and Serum Sodium in Patients with Low Meld Scores. Med Arch 2016;70:48-52. [PMID: 26980932 DOI: 10.5455/medarh.2016.70.48-52] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
313 Shiba S, Chu PS, Nakamoto N, Yamataka K, Taniki N, Ojiro K, Yamaguchi A, Morikawa R, Yoshida A, Ikura A, Ebinuma H, Saito H, Kanai T. Clinical implications with tolvaptan on monitored bioimpedance-defined fluid status in patients with cirrhotic ascites: an observational study. BMC Gastroenterol 2020;20:53. [PMID: 32138675 DOI: 10.1186/s12876-020-01205-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
314 Singal AK, Kamath PS. Model for End-stage Liver Disease. J Clin Exp Hepatol. 2013;3:50-60. [PMID: 25755471 DOI: 10.1016/j.jceh.2012.11.002] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 6.1] [Reference Citation Analysis]
315 Kim TH, Yun SG, Choi J, Goh HG, Lee HA, Yim SY, Choi SJ, Lee YS, Yoon EL, Jung YK, Seo YS, Kim JH, Yim HJ, Yeon JE, Byun KS, Um SH. Differential Impact of Serum 25-Hydroxyvitamin D3 Levels on the Prognosis of Patients with Liver Cirrhosis According to MELD and Child-Pugh Scores. J Korean Med Sci 2020;35:e129. [PMID: 32419396 DOI: 10.3346/jkms.2020.35.e129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]